ECDC reports that antimicrobial resistance shows no signs of slowing down

05 March 2019

Article: 53/903

Data released by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective. The joint report, which presents the findings from humans, pigs and calves under one year of age from across 28 EU member states, confirms the rise in antibiotic resistance already identified in previous years.

According to the report, which refers to 2017 data, resistance to fluoroquinolones (such as ciprofloxacin) in Campylobacter bacteria is so high in some countries, that these antimicrobials no longer work for the treatment of severe campylobacteriosis cases.

Most countries reported that Salmonella in humans is increasingly resistant to fluoroquinolones. Multidrug resistance, to three or more antimicrobials, is high in Salmonella found in humans (28.3%) and animals, particularly in S. typhimurium.

In Campylobacter, high to extremely high proportions of bacteria were found to be resistant to ciprofloxacin and tetracyclines. Combined resistance to critically important antimicrobials was low to very low in Salmonella and Campylobacter from humans and animals, and in indicator E. coli from animals.

Source: EFSA, 26 February 2019